(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 30.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Rapid Micro Biosystems's revenue in 2024 is $22,519,000.On average, 2 Wall Street analysts forecast RPID's revenue for 2024 to be $1,152,572,338, with the lowest RPID revenue forecast at $1,147,430,151, and the highest RPID revenue forecast at $1,157,757,022. On average, 2 Wall Street analysts forecast RPID's revenue for 2025 to be $1,557,402,694, with the lowest RPID revenue forecast at $1,483,159,714, and the highest RPID revenue forecast at $1,631,645,675.
In 2026, RPID is forecast to generate $2,177,099,971 in revenue, with the lowest revenue forecast at $2,177,099,971 and the highest revenue forecast at $2,177,099,971.